Back to Search
Start Over
Secondary Prevention of Stroke with Atrial Fibrillation by New Oral Anticoagulants
Secondary Prevention of Stroke with Atrial Fibrillation by New Oral Anticoagulants
- Source :
- Treatment of Non-vitamin K Antagonist Oral Anticoagulants ISBN: 9789811018770
- Publication Year :
- 2016
- Publisher :
- Springer Singapore, 2016.
-
Abstract
- We used the results of secondary prevention analyses for patients with a history of stroke or TIA in the large-scale RE-LY, ROCKET-AF (J-ROCKET-AF), and ARISTOTLE clinical trials to investigate the choice of new oral anticoagulants (NOACs) to prevent recurrent stroke. In light of these results, we concluded that dabigatran 150 mg BID should be the first-choice treatment for comparatively young patients with no apparent renal dysfunction, and apixaban for other patients, and that their efficacy and safety can be broadly guaranteed.
Details
- ISBN :
- 978-981-10-1877-0
- ISBNs :
- 9789811018770
- Database :
- OpenAIRE
- Journal :
- Treatment of Non-vitamin K Antagonist Oral Anticoagulants ISBN: 9789811018770
- Accession number :
- edsair.doi...........6087cc6d91cdedab377af9d12f69b1f9
- Full Text :
- https://doi.org/10.1007/978-981-10-1878-7_1